Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight: Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 2391 - 2398 of 2398 results

First page
Previous page
240
Next page disabled
Next page disabled

IBRITUMOMAB TIUXETAN

4Q52C550XK

Status:

US Approved Rx (2002)

Source:

BLA125019

(2002)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125019

First approved in 2002

Source:

BLA125019

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ccf29429-bf8e-4cce-bd12-1de56853fc5b

Class:

CONCEPT

BASILIXIMAB

9927MT646M

Status:

US Approved Rx (1998)

Source:

BLA103764

(1998)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103764

First approved in 1998

Source:

BLA103764

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1af01887-b69d-444b-91ed-ebfe12784440

Class:

CONCEPT

RITUXIMAB

4F4X42SYQ6

Status:

US Approved Rx (1997)

Source:

BLA103705

(1997)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103705

First approved in 1997

Source:

BLA103705

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b172773b-3905-4a1c-ad95-bab4b6126563

Class:

CONCEPT

CAPROMAB PENDETIDE

BDO5072GRX

Status:

US Approved Rx (1996)

Source:

BLA103608

(1996)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103608

First approved in 1996

Source:

BLA103608

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103608

Class:

CONCEPT

PEGASPARGASE

7D96IR0PPM

Status:

US Approved Rx (1994)

Source:

BLA103411

(1994)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=103411

First approved in 1994

Source:

BLA103411

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7fc3d37f-df69-484f-9ab1-7ba1c4947898

Class:

CONCEPT

HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN

LUY6P8763W

Status:

US Approved Rx (1989)

Source:

BLA103237

(1989)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 1989

Source:

BLA103237

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9dff46c6-4b15-4d10-aca6-d5ef3735a530

Class:

CONCEPT

PLASMA PROTEIN FRACTION (HUMAN)

6D53G0FD0Z

Status:

US Approved Rx (1958)

Source:

BLA101140

(1958)

Source URL:

https://www.fda.gov/media/113210/download

First approved in 1958

Source:

BLA101140

Source URL:

https://www.fda.gov/media/113210/download

Class:

CONCEPT

PROTAMINE

72G3UY6T4N

Status:

US Approved Rx (1987)

Source:

ANDA089454

(1987)

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=089454

First approved in 1950

Source:

PROTAMINE SULFATE by PHARMACIA AND UPJOHN

Source URL:

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=007413

Class:

CONCEPT

Concept

IBRITUMOMAB TIUXETAN

Concept

BASILIXIMAB

Concept

RITUXIMAB

Concept

CAPROMAB PENDETIDE

Concept

Concept

HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE MENINGOCOCCAL OUTER MEMBRANE PROTEIN CONJUGATE ANTIGEN

Concept

PLASMA PROTEIN FRACTION (HUMAN)

Concept

PROTAMINE

Showing 2391 - 2398 of 2398 results

First page
Previous page
240
Next page disabled
Next page disabled

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1